117 related articles for article (PubMed ID: 26220972)
21. Functional characterization of splicing and ligand-binding domain variants in the LDL receptor.
Etxebarria A; Palacios L; Stef M; Tejedor D; Uribe KB; Oleaga A; Irigoyen L; Torres B; Ostolaza H; Martin C
Hum Mutat; 2012 Jan; 33(1):232-43. PubMed ID: 21990180
[TBL] [Abstract][Full Text] [Related]
22. Two novel D151Y and M391T LDLR mutations causing LDLR transport defects in Thai patients with familial hypercholesterolemia.
Jeenduang N; Ruangpracha A; Promptmas C; Pongrapeeporn KU; Porntadavity S
Clin Chim Acta; 2010 Nov; 411(21-22):1656-61. PubMed ID: 20599862
[TBL] [Abstract][Full Text] [Related]
23. The molecular basis of familial hypercholesterolemia in the Czech Republic: spectrum of LDLR mutations and genotype-phenotype correlations.
Tichý L; Freiberger T; Zapletalová P; Soška V; Ravčuková B; Fajkusová L
Atherosclerosis; 2012 Aug; 223(2):401-8. PubMed ID: 22698793
[TBL] [Abstract][Full Text] [Related]
24. Interaction between the LDL-receptor gene bearing a novel mutation and a variant in the apolipoprotein A-II promoter: molecular study in a 1135-member familial hypercholesterolemia kindred.
Takada D; Emi M; Ezura Y; Nobe Y; Kawamura K; Iino Y; Katayama Y; Xin Y; Wu LL; Larringa-Shum S; Stephenson SH; Hunt SC; Hopkins PN
J Hum Genet; 2002; 47(12):656-64. PubMed ID: 12522687
[TBL] [Abstract][Full Text] [Related]
25. Low-density lipoprotein receptor gene mutation analysis and structure-function correlation in an Omani arab family with familial hypercholesterolemia.
Al-Rasadi K; Al-Waili K; Al-Zidi WA; Al-Abri AR; Al-Hinai AT; Al-Sabti HA; Al-Tobi S; Al-Zakwani I; Al-Zadjali F; Al-Hashmi K; Banerjee Y
Angiology; 2014 Nov; 65(10):911-8. PubMed ID: 24249837
[TBL] [Abstract][Full Text] [Related]
26. Molecular characterization of familial hypercholesterolemia in Spain: identification of 39 novel and 77 recurrent mutations in LDLR.
Mozas P; Castillo S; Tejedor D; Reyes G; Alonso R; Franco M; Saenz P; Fuentes F; Almagro F; Mata P; Pocoví M
Hum Mutat; 2004 Aug; 24(2):187. PubMed ID: 15241806
[TBL] [Abstract][Full Text] [Related]
27. Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia.
Wang H; Xu S; Sun L; Pan X; Yang S; Wang L
PLoS One; 2014; 9(3):e92703. PubMed ID: 24671153
[TBL] [Abstract][Full Text] [Related]
28. Impact of low-density lipoprotein receptor mutational class on carotid atherosclerosis in patients with familial hypercholesterolemia.
Junyent M; Gilabert R; Jarauta E; Núñez I; Cofán M; Civeira F; Pocoví M; Mallén M; Zambón D; Almagro F; Vega J; Tejedor D; Ros E
Atherosclerosis; 2010 Feb; 208(2):437-41. PubMed ID: 19717150
[TBL] [Abstract][Full Text] [Related]
29. The important role for betaVLDLs binding at the fourth cysteine of first ligand-binding domain in the low-density lipoprotein receptor.
Iwasaki T; Takahashi S; Ishihara M; Takahashi M; Ikeda U; Shimada K; Fujino T; Yamamoto TT; Hattori H; Emi M
J Hum Genet; 2004; 49(11):622-628. PubMed ID: 15459764
[TBL] [Abstract][Full Text] [Related]
30. Implications for familial hypercholesterolemia from the structure of the LDL receptor YWTD-EGF domain pair.
Jeon H; Meng W; Takagi J; Eck MJ; Springer TA; Blacklow SC
Nat Struct Biol; 2001 Jun; 8(6):499-504. PubMed ID: 11373616
[TBL] [Abstract][Full Text] [Related]
31. Familial hypercholesterolemia class II low-density lipoprotein receptor response to statin treatment.
Omer L; Hindi L; Militello G; Stivers KB; Tien KC; Boyd NL
Dis Model Mech; 2020 Apr; 13(4):. PubMed ID: 32005714
[TBL] [Abstract][Full Text] [Related]
32. The Arabic allele: a single base pair substitution activates a 10-base downstream cryptic splice acceptor site in exon 12 of LDLR and severely decreases LDLR expression in two unrelated Arab families with familial hypercholesterolemia.
Shawar SM; Al-Drees MA; Ramadan AR; Ali NH; Alfadhli SM
Atherosclerosis; 2012 Feb; 220(2):429-36. PubMed ID: 22129472
[TBL] [Abstract][Full Text] [Related]
33. Novel mutations identification in exon 4 of LDLR gene in patients with moderate hypercholesterolemia in a Venezuelan population.
Arráiz N; Bermúdez V; Rondon N; Reyes F; Borjas L; Solís E; Mujica E; Prieto C; Reyna N; Velasco M
Am J Ther; 2010; 17(3):325-9. PubMed ID: 20019594
[TBL] [Abstract][Full Text] [Related]
34. Familial Hypercholesterolemia in Greek children and their families: genotype-to-phenotype correlations and a reconsideration of LDLR mutation spectrum.
Mollaki V; Progias P; Drogari E
Atherosclerosis; 2014 Dec; 237(2):798-804. PubMed ID: 25463123
[TBL] [Abstract][Full Text] [Related]
35. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China.
Chiou KR; Charng MJ
Gene; 2012 Apr; 498(1):100-6. PubMed ID: 22353362
[TBL] [Abstract][Full Text] [Related]
36. Characterization of residues in the cytoplasmic domain of the LDL receptor required for exit from the endoplasmic reticulum.
Strøm TB; Tveten K; Holla ØL; Cameron J; Berge KE; Leren TP
Biochem Biophys Res Commun; 2011 Dec; 415(4):642-5. PubMed ID: 22079632
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between changes in activities of low density lipoprotein receptor and gene mutation in familial hypercholesterolemia].
Pang Q; Li M; Hu W; Chen Q; Li X; Fan L
Zhonghua Nei Ke Za Zhi; 2002 Oct; 41(10):667-70. PubMed ID: 12485531
[TBL] [Abstract][Full Text] [Related]
38. p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro.
Benito-Vicente A; Siddiqi H; Uribe KB; Jebari S; Galicia-Garcia U; Larrea-Sebal A; Stef M; Ostolaza H; Palacios L; Martin C
Sci Rep; 2018 Nov; 8(1):16614. PubMed ID: 30413722
[TBL] [Abstract][Full Text] [Related]
39. Genetics and kinetics of familial hypercholesterolemia, with the special focus on FH-(Marburg) p.W556R.
Soufi M; Kurt B; Schweer H; Sattler AM; Klaus G; Zschocke J; Schaefer JR
Atheroscler Suppl; 2009 Dec; 10(5):5-11. PubMed ID: 20129366
[TBL] [Abstract][Full Text] [Related]
40. Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia.
Jelassi A; Jguirim I; Najah M; Abid AM; Boughamoura L; Maatouk F; Rouis M; Boileau C; Rabès JP; Slimane MN; Varret M
Atherosclerosis; 2009 Apr; 203(2):449-53. PubMed ID: 18757057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
